Skip to content
New issue

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.

By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.

Already on GitHub? Sign in to your account

feat(route): add World Health Organization News #8022

Merged
merged 2 commits into from
Nov 27, 2021

Conversation

nczitzk
Copy link
Contributor

@nczitzk nczitzk commented Aug 15, 2021

该 PR 相关 Issue / Involved issue

Close #

完整路由地址 / Example for the proposed route(s)

/who/news

新RSS检查列表 / New RSS Script Checklist

  • New Route
  • Documentation
    • CN
    • EN
  • 全文获取 fulltext
    • Use Cache
  • 反爬/频率限制 anti-bot or rate limit?
    • 如果有, 是否有对应的措施? If yes, do your code reflect this sign?
  • 日期和时间 date and time
    • 可以解析 Parsed
    • 时区调整 Correct TimeZone
  • 添加了新的包 New package added
  • Puppeteer

说明 / Note

@vercel
Copy link

vercel bot commented Aug 15, 2021

This pull request is being automatically deployed with Vercel (learn more).
To see the status of your deployment, click below or on the icon next to each commit.

🔍 Inspect: https://vercel.com/diy/rsshub/cqZ7Esu3o9k12mx347WWaGx5Sc2U
✅ Preview: https://rsshub-git-fork-nczitzk-feature-who-news-diy.vercel.app

@github-actions
Copy link
Contributor

Successfully generated as following:

https://rsshub-7vfeza5w4-rsshub-team.vercel.app/who/news - Success
    <?xml version="1.0" encoding="UTF-8"?>
<rss  xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"

>
    <channel>
        <title><![CDATA[News - WHO]]></title>
        <link>https://www.who.int/news</link>
        <atom:link href="https://rsshub-7vfeza5w4-rsshub-team.vercel.app/who/news" rel="self" type="application/rss+xml" />
        <description><![CDATA[News - WHO - Made with love by RSSHub(https://github.com/DIYgod/RSSHub)]]></description>
        <generator>RSSHub</generator>
        <webMaster>[email protected] (DIYgod)</webMaster>
        
        
        
        <language>zh-cn</language>
        
        <lastBuildDate>Sun, 15 Aug 2021 13:26:54 GMT</lastBuildDate>
        <ttl>5</ttl>
        
        <item>
            <title><![CDATA[Medical Product Alert N°4/2021: Falsified remdesivir]]></title>
            <description><![CDATA[<p></p><h3 style="\"text-align:left;\""><strong style="\"font-size:16px;text-align:left;\""></strong><strong>Alert Summary </strong></h3><div></div><div>This WHO Medical Product Alert refers to two batches of falsified remdesivir injection 100mg/20ml (5mg/ml)</div><div>identified in the WHO Region of the Americas and reported to WHO in July 2021. These products claim to be</div><div>manufactured by GILEAD. However, GILEAD has confirmed that the remdesivir products listed in this alert are</div><div>falsified and were not manufactured by them. These falsified products have been reported at the patient level <span style="\"background-color:transparent;color:#3c4245;font-family:Arial," helvetica, sans-serif;font-size:16px;text-align:inherit;text-transform:inherit;white-space:inherit;word-spacing:normal;caret-color:auto;\">(including at a hospital) in Mexico and are illicitly supplied on the internet.</span></div><div><p><span style="\"background-color:initial;color:#313131;font-size:inherit;font-family:inherit;text-align:inherit;text-transform:inherit;white-space:inherit;word-spacing:normal;caret-color:auto;\"">Remdesivir is a broad-spectrum antiviral medication that was approved or authorized for emergency use to treat </span><span style="\"background-color:initial;color:#313131;font-size:inherit;font-family:inherit;text-align:inherit;text-transform:inherit;white-space:inherit;word-spacing:normal;caret-color:auto;\"">COVID-19 in several countries. In November 2020, WHO updated a conditional recommendation against </span><span style="\"background-color:initial;color:#313131;font-size:inherit;font-family:inherit;text-align:inherit;text-transform:inherit;white-space:inherit;word-spacing:normal;caret-color:auto;\"">remdesivir in hospitalized patients with COVID-19. This recommendation is part of the <a target="\"_blank\"" href="https://www.who.int/%22/publications/i/item/WHO-2019-nCoV-therapeutics-2021.2/%22">WHO Therapeutics <span style="\"background-color:initial;color:#313131;font-size:inherit;font-family:inherit;text-align:inherit;text-transform:inherit;white-space:inherit;word-spacing:normal;caret-color:auto;\"">and COVID-19: living guideline</span></a> and states “A conditional recommendation is issued when the evidence </span><span style="\"background-color:initial;color:#313131;font-size:inherit;font-family:inherit;text-align:inherit;text-transform:inherit;white-space:inherit;word-spacing:normal;caret-color:auto;\"">around the benefits and risks of intervention are less certain. In this case, there is a conditional recommendation</span><span style="\"background-color:initial;color:#313131;font-size:inherit;font-family:inherit;text-align:inherit;text-transform:inherit;white-space:inherit;word-spacing:normal;caret-color:auto;\""> against the use of remdesivir. This means that there isn’t enough evidence to support its use.”</span></p></div><div>The products identified in this alert are confirmed as falsified on the basis that they deliberately / fraudulently</div><div>misrepresent their identity, composition, or source. The composition of the vials is currently unknown and <span style="\"background-color:transparent;color:#3c4245;font-family:Arial," helvetica, sans-serif;font-size:16px;text-align:inherit;text-transform:inherit;white-space:inherit;word-spacing:normal;caret-color:auto;\">laboratory analyses are to be conducted.</span></div><div><p> </p></div><div></div><ul><li><span style="\"background-color:initial;color:#313131;font-size:inherit;font-family:inherit;text-align:inherit;text-transform:inherit;white-space:inherit;word-spacing:normal;caret-color:auto;\"">Batch EN2005A2-B: the batch number and the expiry date (06/2023) do not correspond to any </span>remdesivir manufactured by GILEAD.</li><li>Batch EN2009D7-Q: the batch number does not correspond to any remdesivir manufactured by GILEAD.</li></ul><p><br></p><p> </p><p><strong>Table 1: Products subject of WHO Medical Product Alert N°4/2021</strong></p><img 1 alt="\"Table" n4.2021_en\" src="https://www.who.int/%22/images/default-source/substandard-and-falsified-medical-products/table1_n4.2021_en.png?Status=Master&sfvrsn=e05ace1c_5\%22" sf-size="\"30352\"" referrerpolicy="no-referrer"><br><h3><strong>Advice to regulatory authorities and the public</strong></h3><p>WHO requests increased vigilance within the supply chains of countries and regions likely to be affected by these falsified products. Increased vigilance should include hospitals, clinics, health centers, wholesalers, distributors, pharmacies, and any other suppliers of medical products.</p><p>All medical products must be obtained from authorized/licensed suppliers. The products’ authenticity and physical condition should be carefully checked. Seek advice from a healthcare professional in case of doubt.</p><p>If you are in possession of the above products, please do not use them.</p><p>If you have used these products, or you suffered an adverse reaction/event having used these products, you are advised to seek immediate medical advice from a qualified healthcare professional and to report the incident to the National Regulatory Authorities/National Pharmacovigilance Centre.</p><div>National regulatory / health authorities are advised to immediately notify WHO if these falsified products are</div><div>discovered in their country. If you have any information concerning the manufacture, distribution, or supply of</div><div>these products, please contact <a target="\"_blank\"" href="https://www.who.int/%22mailto:[email protected]/%22">[email protected]</a></div><p><span style="\"text-decoration:underline;\""> </span></p><p><strong>Table 2: Photographs of products subject of WHO Medical Product Alert N°4/2021</strong></p><p><img 2 alt="\"Table" n4.2021_en\" src="https://www.who.int/%22/images/default-source/substandard-and-falsified-medical-products/table2_n4.2021_en.png?Status=Master&sfvrsn=caf011b9_5\%22" sf-size="\"237315\"" referrerpolicy="no-referrer"><br></p><p><br></p><div><p align="\"center\"" style="\"text-align:center;\""><strong> </strong></p><p align="\"center\"" style="\"text-align:center;\""><strong>WHO Global Surveillance and Monitoring System </strong></p><p align="\"center\"" style="\"text-align:center;\""><strong>for Substandard and Falsified Medical Products</strong></p><p align="\"center\"" style="\"text-align:center;\"">For more information, please visit our <a target="\"_blank\"" href="https://www.who.int/%22/health-topics/substandard-and-falsified-medical-products#tab=tab_1\%22">website</a></p><p align="\"center\"" style="\"text-align:center;\""><span style="\"text-decoration:underline;\"">Email: <span style="\"text-decoration:underline;\""><a target="\"_blank\"" href="https://www.who.int/%22mailto:[email protected]/%22">[email protected]</a></span> <span style="\"text-decoration:underline;\""></span></span></p></div><p> </p><p> </p><p> </p><h2 align="\"center\"" style="\"text-align:center;\""></h2><div><hr align="\"left\"" size="\"1\"" width="\"33%\""><div id="\"ftn1\""><p><span style="\"text-decoration:underline;\""> </span></p></div></div><p></p>]]></description>
            <pubDate>Fri, 13 Aug 2021 08:12:00 GMT</pubDate>
            <guid isPermaLink="false">https://www.who.int/news/item//13-08-2021-medical-product-alert-n-4-2021-falsified-remdesivir</guid>
            <link>https://www.who.int/news/item//13-08-2021-medical-product-alert-n-4-2021-falsified-remdesivir</link>
            
            
            
            
            

@github-actions github-actions bot added the Auto: Route Test Complete Auto route test has finished on given PR label Aug 15, 2021
@github-actions
Copy link
Contributor

Successfully generated as following:

https://rsshub-59z7butxj-diy.vercel.app/who/news - Success
    <?xml version="1.0" encoding="UTF-8"?>
<rss  xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"

>
    <channel>
        <title><![CDATA[News - WHO]]></title>
        <link>https://www.who.int/news</link>
        <atom:link href="https://rsshub-59z7butxj-diy.vercel.app/who/news" rel="self" type="application/rss+xml" />
        <description><![CDATA[News - WHO - Made with love by RSSHub(https://github.com/DIYgod/RSSHub)]]></description>
        <generator>RSSHub</generator>
        <webMaster>[email protected] (DIYgod)</webMaster>
        
        
        
        <language>zh-cn</language>
        
        <lastBuildDate>Sat, 27 Nov 2021 07:31:52 GMT</lastBuildDate>
        <ttl>5</ttl>
        
        <item>
            <title><![CDATA[Streets for Life campaign presented with Prince Michael International Road Safety Award]]></title>
            <description><![CDATA[<p>The Streets for Life #Love30 campaign for the <a href="https://www.who.int/%22https://www.unroadsafetyweek.org/en/home/%22">6th UN Global Road Safety Week</a> has been presented with a 2021 Prince Michael International Road Safety Award. The prestigious award is presented each year to examples of outstanding international road safety initiatives. <br></p><p>The Streets for Life #Love30 campaign was organized under the auspices of the UN Road Safety Collaboration (UNRSC) for the 6th UN Global Road Safety Week by the World Health Organization, FIA Foundation, YOURS - Youth for Road Safety and the Global Alliance of NGOs for Road Safety. The campaign focused on a specific policy objective: promoting and advocating for 30 km/h (20 mph) streets where people live, walk and play. The low-speed interventions were framed as life-saving, low-cost and achievable measures to reduce road traffic deaths and injuries and facilitate multiple benefits for health, environment and equity. Through the campaign, UNRSC members, NGOs, youth activists and others in at least 53 countries around the world were mobilized to advocate for endorsements of and commitments for 30 km/h speed limits. <br></p><p>The <a href="https://www.who.int/%22https://www.mystreet.org/streets-for-life/%22">Streets for Life call to action</a> was endorsed by ministers, mayors and leaders from international agencies including Dr. Tedros Adhanom Ghebreyesus, Director-General, WHO; Henrietta Fore, Executive Director, UNICEF; Inger Andersen, Executive Director, UN Environment Programme; Achim Steiner, Administrator, UN Development Programme; Jean Todt, UN Secretary General’s Special Envoy for Road Safety and FIA President; Tomas Eneroth, Minister for Infrastructure, Sweden; Jayathma Wickramanayake, UN Secretary General's Envoy on Youth; Ángela María Orozco Gómez, Minister of Transport, Colombia; James Wainaina Macharia, Cabinet Secretary for Transport, Kenya; Anne Hidalgo, Mayor of Paris; Lord Robertson, Chairman, FIA Foundation; and Zoleka Mandela, Global Ambassador, Child Health Initiative.<br></p><p>As a result of the campaign, long-lasting efforts spearheaded by local NGOs are being seen on a global scale. The process toward national policies for 30 km/h limits where people live, walk and play has been initiated in several countries. Meanwhile, reduced speed limits in local streets and zones are being implemented in cities around the world.<br></p><p>His Royal Highness Prince Michael of Kent said, “This highly effective campaign is an outstanding example of how collaboration between NGOs can make a real difference.”<br></p><p>“My colleagues and I are proud supporters of the Streets for Life #Love30 campaign”, notes Dr Etienne Krug, Director of the Department for Social Determinants of Health at the World Health Organization. “Low-speed streets in urban areas are among the most effective measures. Congratulations to all involved for this highly successful campaign which is an inspiration for cities everywhere.”  <br></p><p>Saul Billingsley, Executive Director of the FIA Foundation, said: “Streets for Life has been a hugely impactful campaign, one which has caught the imagination and delivered the message incredibly effectively. It is a simple, yet powerful concept, calling upon policy makers to deliver low-speed, liveable streets for all. The call to action gained support at the highest levels, and across cities and countries around the world. It was heartening to see policy makers commit to real change as a result. Working in coalition with NGOs, youth advocates and campaigners, we’re immensely proud of this initiative. This is just the start, however. Let’s hope we can build on this success, continuing to push for real transformation and lives saved.”<br></p><p>Floor Lieshout, Executive Director, YOURS - Youth for Road Safety said, “The Streets for Life campaign has been exemplary for what synergetic international collaboration can do. The trust, passion and partnership between all stakeholders has made this 6th UN Global Road Safety Week a great success. A massive congratulations to all who shaped, supported and took part in the campaign. Together we will continue our #Love30 journey and hold our leaders accountable to create 30 km/h streets where people and traffic mix.\"</p><p><span style="\"background-color:initial;color:#333333;font-size:inherit;font-family:inherit;text-align:inherit;text-transform:inherit;white-space:inherit;word-spacing:normal;caret-color:auto;\"">Lotte Brondum, Executive Director, Global Alliance of NGOs for Road Safety said, “This award is a testament to the value of local advocates, speaking on behalf of their communities and making a tangible impact with their decision makers to save lives. I congratulate each and every NGO, youth activist, and others who took part in the campaign and encourage them to continue their call for 30 </span>km/h in their streets, cities, and countries.”</p>]]></description>
            <pubDate>Fri, 26 Nov 2021 20:00:00 GMT</pubDate>
            <guid isPermaLink="false">https://www.who.int/news/item//26-11-2021-streets-for-life-campaign-presented-with-prince-michael-international-road-safety-award</guid>
            <link>https://www.who.int/news/item//26-11-2021-streets-for-life-campaign-presented-with-prince-michael-international-road-safety-award</link>
            
            
            
            
            

auto-bot-ty added a commit to auto-bot-ty/RSSHub that referenced this pull request Nov 27, 2021
* docs: update sponsor

* feat: add hotukdeals

* feat: hotukdeals radar

* feat: add PS5 stock UK - The Independent

* fix(route): allow preLoginFlow of instagram to fail (DIYgod#8340)

Based on discussion in instragram-private-api repo, we do not need
this function for login.

See:
dilame/instagram-private-api#1411
dilame/instagram-private-api#1417

* style: auto format

* feat: pixiv PIXIV_IMG_PROXY

* fix: douban guid

* feat(route): add Research Gate Publications (DIYgod#7544)

* feat(route): add QuestMobile行业研究报告 (DIYgod#7552)

* chore: remove no-return-await eslint rule

* feat(route): add RSS3 Blog (DIYgod#7566)

Co-authored-by: DIYgod <[email protected]>

* style: auto format

* feat(route): add Odaily星球日报活动 (DIYgod#7666)

* feat: remove toutiao

* chore: format

* feat(route): add fashion network news (DIYgod#7602)

Co-authored-by: DIYgod <[email protected]>

* feat(route): add dbaplus社群活动 (DIYgod#7584)

Co-authored-by: DIYgod <[email protected]>

* feat(route): add 德阳考试中心 (DIYgod#7901)

* feat(route): add 央视网栏目 (DIYgod#7937)

Co-authored-by: DIYgod <[email protected]>

* style: auto format

* fix: infzm timezone (DIYgod#7695)

* fix: undefined error when no magnet & torrent (DIYgod#7745)

* feat(route): add World Health Organization News (DIYgod#8022)

Co-authored-by: DIYgod <[email protected]>

* fix: exclude datanews to prevent `pubDate` error (`/caixin/latest`) (DIYgod#8068)

* feat(route): add World Health Organization Speeches (DIYgod#8048)

Co-authored-by: DIYgod <[email protected]>

* Fix AP News article's title (DIYgod#8086)

* feat(route): add Now 熱門新聞 (DIYgod#8093)

Co-authored-by: DIYgod <[email protected]>

* feat(route): add Uwants (DIYgod#8094)

Co-authored-by: DIYgod <[email protected]>

* fix: lazyloadRouteHandler

* fix: add Lofter话题/标签文章分类 & 视频 (DIYgod#8054)

* feat(route): add yunnan normal university (DIYgod#8097)

* feat(route): add 香港討論區 (DIYgod#8101)

Co-authored-by: DIYgod <[email protected]>

* feat(route): add 香港高登 (DIYgod#8109)

Co-authored-by: DIYgod <[email protected]>

* feat(route): add 华南理工大学教务处学院通知 (DIYgod#8110)

* fix(route): incorrect source links in yuzu emulator (DIYgod#8111)

* fix(route): migrate initium routes to new timezone (DIYgod#8124)

* feat(route): add yahoo japan covid19 news collection 日本疫情消息汇总 (DIYgod#8099)

* feat(route): add Asian to lick (DIYgod#8156)

Co-authored-by: SettingDust <[email protected]>
Co-authored-by: DIYgod <[email protected]>

* feat(route): add "micmicidol" (DIYgod#8070)

Co-authored-by: SettingDust <[email protected]>
Co-authored-by: DIYgod <[email protected]>

* feat(route):add 拷贝漫画 (DIYgod#7896)

Co-authored-by: SettingDust <[email protected]>
Co-authored-by: DIYgod <[email protected]>

* feat(route): add SBS中文 (DIYgod#8149)

Co-authored-by: DIYgod <[email protected]>

* feat(route): add Netflix Newsroom (DIYgod#8135)

Co-authored-by: SettingDust <[email protected]>
Co-authored-by: NeverBehave <[email protected]>
Co-authored-by: DIYgod <[email protected]>

* fix(route): 修正北京教育考试院内容提取错误 (DIYgod#8209)

* fix(route): dekudeals error due to ad (DIYgod#8214)

* feat(route): add 旺球体育直播间 (DIYgod#8276)

Co-authored-by: DIYgod <[email protected]>

* fix(route): 深圳证券交易所最新规则 (DIYgod#8284)

* feat(route): add 人民网领导留言板 (DIYgod#8285)

* feat(router): timednews 时刻新闻 (DIYgod#8279)

Co-authored-by: Tony <[email protected]>

* feat(router): ccac 澳门廉政公署 (DIYgod#8273)

Co-authored-by: Tony <[email protected]>

* add 安全文摘 (DIYgod#8294)

Co-authored-by: testkaili <[email protected]>
Co-authored-by: kaiili <[email protected]>

* feat(router): cebbank 光大银行 (DIYgod#8293)

* feat(route): add NGOCN (DIYgod#8301)

Co-authored-by: DIYgod <[email protected]>

* chore: format

* feat(route): add IT之家专题 (DIYgod#8312)

* feat(route)(v2): add 旅法师营地首页 (DIYgod#8350)

* feat(route): add 辛華社 (DIYgod#8357)

* feat(route): add Literotica Category (DIYgod#8415)

* feat(route): add Literotica News Stories (DIYgod#8410)

Co-authored-by: DIYgod <[email protected]>

* misc: add NOROUTE instruction back to template (DIYgod#8379)

Co-authored-by: Sukka <[email protected]>

* feat(route): jandan use the origin gif instead the thumbs (DIYgod#8406)

* feat(route): add HKJunkCall資訊中心 (DIYgod#8405)

* fix(route): fix furstar pic href (DIYgod#8404)

* feat(route): add ScienceDirect Journal (DIYgod#8399)

* feat(route): add Harvard Business Review Topic (DIYgod#8395)

* fix(route)(hket): migrate to v2 (DIYgod#8132)

* chore: format

Co-authored-by: DIYgod <[email protected]>
Co-authored-by: Shizun Ge <[email protected]>
Co-authored-by: GitHub Action <[email protected]>
Co-authored-by: Ethan Shen <[email protected]>
Co-authored-by: DIYgod <[email protected]>
Co-authored-by: zytomorrow <[email protected]>
Co-authored-by: Sean Chao <[email protected]>
Co-authored-by: junfengP <[email protected]>
Co-authored-by: Toby Tso <[email protected]>
Co-authored-by: ninboy <[email protected]>
Co-authored-by: SettingDust <[email protected]>
Co-authored-by: Rongrong <[email protected]>
Co-authored-by: coxde <[email protected]>
Co-authored-by: sgqy <[email protected]>
Co-authored-by: KotoriK <[email protected]>
Co-authored-by: btdwv <[email protected]>
Co-authored-by: NeverBehave <[email protected]>
Co-authored-by: erriy <[email protected]>
Co-authored-by: Kevin Carter <[email protected]>
Co-authored-by: linbuxiao <[email protected]>
Co-authored-by: Tony <[email protected]>
Co-authored-by: kaiili <[email protected]>
Co-authored-by: testkaili <[email protected]>
Co-authored-by: kaiili <[email protected]>
Co-authored-by: auto-bot-ty <[email protected]>
Co-authored-by: Yishuai Li <[email protected]>
Co-authored-by: Sukka <[email protected]>
Co-authored-by: Oddcc <[email protected]>
Co-authored-by: tuzi3040 <[email protected]>
@nczitzk nczitzk deleted the feature/who-news branch November 27, 2021 11:06
Sign up for free to join this conversation on GitHub. Already have an account? Sign in to comment
Labels
Auto: Route Test Complete Auto route test has finished on given PR
Projects
None yet
Development

Successfully merging this pull request may close these issues.

2 participants